Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from Baraclude to Enped in virologically suppressed adults with chronic hepatitis B
KCT0009610Phase 4Completed
- Sponsor
- Samil Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Samil Pharmaceutical Co., Ltd.. Started Dec 2024; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on KCT0009610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009610.